22157.jpg
Global $6.56 Billion Regenerative Medicine for Cartilage Markets, 2015-2020, 2020-2025F, 2030F
07 mai 2021 04h08 HE | Research and Markets
Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Regenerative Medicine for Cartilage Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's...
Bone Therapeutics to host Annual General Meeting on 9 June 2021
07 mai 2021 01h00 HE | Bone Therapeutics SA
REGULATED INFORMATION Preliminary documents for the Annual General Meeting have been made available on company’s website Gosselies, Belgium, 7 May 2021, 7am CEST – BONE THERAPEUTICS (Euronext...
Bone Therapeutics tiendra son Assemblée Générale Ordinaire le 9 juin 2021
07 mai 2021 01h00 HE | Bone Therapeutics SA
INFORMATION RÉGLEMENTÉE Mise à disposition des documents préparatoires à l’assemblée générale ordinaire sur le site internet de la Société Gosselies, Belgique, le 7 mai 2021 à...
Talaris_large_rgb.png
Talaris Therapeutics Announces Pricing of Initial Public Offering
06 mai 2021 21h53 HE | Talaris Therapeutics, Inc.
BOSTON and LOUISVILLE, Ky., May 06, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc., a late-clinical stage cell therapy company developing therapies with the potential to transform the standard...
Bone Therapeutics announces 2020 full year results
29 avr. 2021 01h00 HE | Bone Therapeutics SA
REGULATED INFORMATION   Ongoing clinical progress across pipeline, including Phase III and IIb clinical trials Multiple new collaborations and partnerships to enhance development, manufacturing...
Bone Therapeutics publie ses résultats annuels 2020
29 avr. 2021 01h00 HE | Bone Therapeutics SA
INFORMATION RÉGLEMENTÉE Fortes avancées cliniques sur l’ensemble du portefeuille de produits, dont les essais cliniques de Phase IIb et III Mise en place de nouvelles collaborations et...
Cytovia.png
Stanley R. Frankel, MD, FACP joins Cytovia Therapeutics as Chief Medical Officer
28 avr. 2021 13h16 HE | Cytovia Therapeutics
CAMBRIDGE, Mass. and AVENTURA, Fla., April 28, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited Chimeric Antigen...
Sana_Logo_RGB-72_Blue.png
Sana Biotechnology to Present Pre-Clinical Data at American Society of Gene & Cell Therapy Annual Meeting 2021
27 avr. 2021 16h35 HE | Sana Biotechnology, Inc
— Fusogen platform demonstrates potential for cell-specific in vivo delivery of gene therapies to multiple cell types, including T cells and hepatocytes — SEATTLE, April 27, 2021 (GLOBE NEWSWIRE)...
Adaptimmune logo Colour_white background_no strap.jpg
Adaptimmune to Present First Preclinical Data from its HLA-independent TCR (HiT) Platform at ASGCT
27 avr. 2021 16h30 HE | Adaptimmune Therapeutics plc
PHILADELPHIA and OXFORDSHIRE, United Kingdom, April 27, 2021 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report initial preclinical...
22157.jpg
Global Advanced Therapy Medicinal Products Industry (2020 to 2027) - Market Trajectory & Analytics
27 avr. 2021 07h34 HE | Research and Markets
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Advanced Therapy Medicinal Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the...